By maintaining oversight across prescribing and dispensing stages, MEDVi supports consistent treatment progression throughout the weight loss process
Novo Nordisk cited its commitment to financial discipline and shareholder value as the main reason for pulling out
Before starting GLP-1 treatment , inform your GP about: Current or previous anxiety disorders , including generalised anxiety disorder, panic disorder, social anxiety, or health anxiety Other mental health conditions such as depression, eating disorders, or obsessive-compulsive disorder Current psychiatric medications , as weight loss may affect medication requirements though GLP-1 medications themselves have few direct drug interactions Previous experiences with weight loss or diabetes medications and any associated mood changes Your support network and coping strategies for managing stress and anxiety Your GP can help establish baseline mental health status and develop a monitoring plan
Free Radic Biol Med 122: 116- 129 Terai Y, Ueno H, Ogawa T, Sawa Y, Miyagi A, Kawai-Yamada M, Ishikawa T, Maruta T (2020) Dehydroascorbate reductases and glutathione set a threshold for high light-induced ascorbate accumulation
